Bridgewater Associates Portfolio holdings
Bridgewater Associates, founded in 1975 by Ray Dalio in New York and now headquartered in Westport, Connecticut, is the world’s largest hedge fund, managing over $125 billion in assets as of late 2024, serving institutional clients like pension funds, endowments, and sovereign wealth funds. Known for its pioneering "Pure Alpha" and "All Weather" strategies, the firm uses a systematic, macroeconomic approach to deliver uncorrelated returns and risk parity across global markets, including equities, bonds, currencies, and commodities, guided by rigorous data analysis and radical transparency. Dalio, who stepped down as co-CIO in 2022, built a unique culture of "radical truth" and "thoughtful disagreement," documented in his book *Principles*, though the firm transitioned leadership to co-CEOs Nir Bar Dea and Mark Bertolini in 2023 amid succession planning. With around 1,300 employees and a history of navigating crises like 2008 with gains, Bridgewater remains a titan in alternative investments, blending intellectual rigor with a distinctive, often polarizing management philosophy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$182M |
| 2 |
Qualcomm
QCOM
|
+$134M |
| 3 |
Apple
AAPL
|
+$126M |
| 4 |
Constellation Energy
CEG
|
+$114M |
| 5 |
Broadcom
AVGO
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$338M |
| 2 |
Johnson & Johnson
JNJ
|
+$276M |
| 3 |
Walmart Inc
WMT
|
+$270M |
| 4 |
Costco
COST
|
+$236M |
| 5 |
McDonald's
MCD
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.09% |
| 3 | Healthcare | 10.72% |
| 4 | Consumer Staples | 9.72% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $709K | ﹤0.01% |
8,826
| – | – |
|
652
Bright Horizons
BFAM
$4.01B
| $702K | ﹤0.01% |
+5,008
| New | +$648K |
|
653
Phreesia
PHR
$698M
| $694K | ﹤0.01% |
30,445
-31,869
| -51% | -$746K |
|
654
Boston Beer
SAM
$1.94B
| $692K | ﹤0.01% |
2,392
-442
| -16% | -$123K |
|
655
J&J Snack Foods
JJSF
$1.48B
| $689K | ﹤0.01% |
4,002
-622
| -13% | -$104K |
|
656
Ingles Markets
IMKTA
$1.74B
| $681K | ﹤0.01% |
9,127
-9,992
| -52% | -$735K |
|
657
Ventas
VTR
$46.6B
| $674K | ﹤0.01% |
10,517
-5,125
| -33% | -$299K |
|
658
BioNTech
BNTX
$23.3B
| $674K | ﹤0.01% |
+5,673
| New | +$522K |
|
659
Plexus
PLXS
$6.98B
| $664K | ﹤0.01% |
+4,856
| New | +$589K |
|
660
Integer Holdings
ITGR
$4.23B
| $661K | ﹤0.01% |
5,088
-11,208
| -69% | -$1.37M |
|
661
Halozyme
HALO
$9.76B
| $659K | ﹤0.01% |
11,515
-21,706
| -65% | -$1.24M |
|
662
Toro Company
TTC
$9.06B
| $646K | ﹤0.01% |
7,445
-1,074
| -13% | -$96.6K |
|
663
Hewlett Packard
HPE
$66.5B
| $645K | ﹤0.01% |
31,524
-35,680
| -53% | -$682K |
|
664
AMN Healthcare
AMN
$1.28B
| $638K | ﹤0.01% |
15,060
-62,723
| -81% | -$3.29M |
|
665
ICU Medical
ICUI
$4.32B
| $631K | ﹤0.01% |
3,464
-324
| -9% | -$48K |
|
666
Haemonetics
HAE
$3.94B
| $629K | ﹤0.01% |
7,826
-35,747
| -82% | -$2.89M |
|
667
National Healthcare
NHC
$3.48B
| $620K | ﹤0.01% |
4,928
-5,449
| -53% | -$685K |
|
668
NovoCure
NVCR
$1.78B
| $616K | ﹤0.01% |
39,383
-41,898
| -52% | -$760K |
|
669
Accenture
ACN
$101B
| $609K | ﹤0.01% |
1,723
-19,852
| -92% | -$6.53M |
|
670
Enviri
NVRI
$651M
| $607K | ﹤0.01% |
58,697
-82,021
| -58% | -$863K |
|
671
Canadian Imperial Bank of Commerce
CM
$109B
| $601K | ﹤0.01% |
+9,784
| New | +$530K |
|
672
Erie Indemnity
ERIE
$12.4B
| $595K | ﹤0.01% |
1,103
-1,686
| -60% | -$767K |
|
673
Enerpac Tool Group
EPAC
$1.85B
| $592K | ﹤0.01% |
+14,143
| New | +$567K |
|
674
Regeneron Pharmaceuticals
REGN
$78.2B
| $586K | ﹤0.01% |
557
-4,797
| -90% | -$5.34M |
|
675
Equitable Holdings
EQH
$13.1B
| $564K | ﹤0.01% |
+13,414
| New | +$550K |
|
Similar funds
Bridgewater Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Bridgewater Associates held 956 positions worth $17.7B, down 7.8% from $19.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bridgewater Associates withdrew a net $2.45B in Q3 2024, closing 183 positions and reducing 428 holdings. Its most notable exit was Walt Disney, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bridgewater Associates opened a new position in Micron Technology worth $102M.
- Bridgewater Associates's largest Q3 2024 buy was Micron Technology: 983,685 shares worth $102M.
- Bridgewater Associates added most to Lam Research in Q3 2024, an estimated $182M increase.
- Bridgewater Associates's biggest Q3 2024 reduction was Procter & Gamble, cutting an estimated $338M.
- Bridgewater Associates fully exited Walt Disney in Q3 2024, selling an estimated $19.4M.
- Bridgewater Associates's ten largest holdings make up 32% of its $17.7B portfolio in Q3 2024.
- Bridgewater Associates opened 79 new positions and closed 183 in Q3 2024.
- Bridgewater Associates's portfolio value fell 7.8% quarter-over-quarter to $17.7B.
Based on Bridgewater Associates's 13F filing for Q3 2024, filed 13 Nov 2024.